张亚, .何凯. 川崎病病因与发病机制的研究进展. 2025. biomedRxiv.202510.00016
川崎病病因与发病机制的研究进展
通讯作者: .何凯
DOI:10.12201/bmr.202510.00016
Corresponding author: HE kai
-
摘要:川崎病(Kawasaki disease, KD)是一种主要累及5岁以下儿童的急性全身性血管炎,是儿童获得性心脏病的首要原因。其病因尚不明确,目前普遍认为是在遗传易感个体中由感染因素触发的异常免疫反应所致。近年来研究显示,多个基因多态性与疾病易感性和冠脉病变相关;多种病原体可能通过超抗原激活等机制诱发免疫应答;免疫机制上,中性粒细胞胞外诱捕网形成、细胞亚群失衡及细胞异常活化共同促进了血管炎症的发生。本文系统综述川崎病在遗传、感染及免疫方面的病因与发病机制研究新进展,以期为疾病早期诊断、风险预警和治疗提供理论依据。
Abstract: Kawasaki disease is an acute systemic vasculitis mainly affecting children under 5 years old, and has become the leading cause of acquired heart disease in children. The etiology is not yet fully understood, and it is generally believed to be caused by abnormal immune responses triggered by infectious factors in genetically susceptible individuals. In recent years, studies have shown that polymorphisms in multiple genes such as ITPKC and CASP3 are associated with disease susceptibility and risk of coronary artery disease; Multiple pathogens such as Staphylococcus aureus, influenza virus, adenovirus, etc. may induce immune responses through mechanisms such as superantigen activation and molecular mimicry; In terms of immune mechanism, the formation of neutrophil extracellular traps (NETs), imbalance of T cell subsets, and abnormal activation of B cells jointly promote the occurrence and development of vascular inflammation. This article systematically reviews the new progress in the etiology and pathogenesis of Kawasaki disease in terms of genetics, infection, and immunity, in order to provide theoretical basis for early diagnosis, risk warning, and treatment of the disease.
Key words: Kawasaki disease; pathogeny; Pathogenesis; Genetic susceptibility; Infection factors; immune activation提交时间:2025-10-11
版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。 -
图表
-
夏刚山, 张明明, 李晓惠. 血小板-白细胞聚集体在川崎病发病机制的研究进展. 2025. doi: 10.12201/bmr.202502.00058
刘凯峰, 申泽涛. 1型Modic改变病因及发病机制的研究进展. 2025. doi: 10.12201/bmr.202505.00049
成路平, 吴思扬, 路波. 基于机器学习的2型糖尿病发病因素分析与预测. 2025. doi: 10.12201/bmr.202509.00003
宋晓波, 陈望强. 少弱精症的病因机制与西医治疗策略研究进展. 2025. doi: 10.12201/bmr.202503.00063
张冰, 牛丽娜, 王晓忠*. 破解难题:肝硬化继发骨质疏松发病机制与防治策略. 2024. doi: 10.12201/bmr.202412.00024
李亚琦. 新冠病毒感染诱导紫癜性肾炎的发病机制. 2024. doi: 10.12201/bmr.202409.00034
林贤, 李杰萍. 热射病的线粒体受损机制研究进展. 2024. doi: 10.12201/bmr.202410.00030
冯丽颖, 谭军华. MiRNA在狼疮肾炎发病机制中研究进展. 2024. doi: 10.12201/bmr.202407.00052
景鹏举, 陈海伟, 王志强, 成鹏. 异位骨化的分子机制与靶向治疗研究进展. 2025. doi: 10.12201/bmr.202506.00002
张红吉, 刁婷婷, 李晓非. 布鲁氏菌致骨损伤机制的研究进展. 2024. doi: 10.12201/bmr.202411.00041
-
序号 提交日期 编号 操作 1 2025-09-05 bmr.202510.00016V1
下载 -
-
公开评论 匿名评论 仅发给作者
引用格式
访问统计
- 阅读量:30
- 下载量: 0
- 评论数:0